461 related articles for article (PubMed ID: 12046982)
21. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
Bell JA; Beglan CL
Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
[TBL] [Abstract][Full Text] [Related]
22. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
[TBL] [Abstract][Full Text] [Related]
24. Involvement of dopaminergic receptor signaling in the effects of glutamatergic receptor antagonists on conditioned place aversion induced by naloxone in single-dose morphine-treated rats.
Kawasaki Y; Araki H; Suemaru K; Kitamura Y; Gomita Y; Sendo T
J Pharmacol Sci; 2011; 117(1):27-33. PubMed ID: 21821972
[TBL] [Abstract][Full Text] [Related]
25. Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine.
McDonald RV; Parker LA; Siegel S
Pharmacol Biochem Behav; 1997 Dec; 58(4):1003-8. PubMed ID: 9408206
[TBL] [Abstract][Full Text] [Related]
26. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
[TBL] [Abstract][Full Text] [Related]
27. Morphine-induced place preference: involvement of the central amygdala NMDA receptors.
Rezayof A; Golhasani-Keshtan F; Haeri-Rohani A; Zarrindast MR
Brain Res; 2007 Feb; 1133(1):34-41. PubMed ID: 17184750
[TBL] [Abstract][Full Text] [Related]
28. Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.
Li Y; Wang H; Qi K; Chen X; Li S; Sui N; Kirouac GJ
Physiol Behav; 2011 Jan; 102(1):42-50. PubMed ID: 20951152
[TBL] [Abstract][Full Text] [Related]
29. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice.
Valero E; Gómez-Milanés I; Almela P; Ribeiro Do Couto B; Laorden ML; Milanés MV; Núñez C
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):102-114. PubMed ID: 29407532
[TBL] [Abstract][Full Text] [Related]
30. Effects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in rats.
Yu H; Wen D; Ma C; Meng Y; Li S; Ni Z; Cong B
PLoS One; 2012; 7(7):e41860. PubMed ID: 22848639
[TBL] [Abstract][Full Text] [Related]
31. Differential effect of beta-adrenergic receptor antagonism in basolateral amygdala on reconsolidation of aversive and appetitive memories associated with morphine in rats.
Wu Y; Li Y; Yang X; Sui N
Addict Biol; 2014 Jan; 19(1):5-15. PubMed ID: 22458530
[TBL] [Abstract][Full Text] [Related]
32. Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine.
Parker LA; Joshi A
Pharmacol Biochem Behav; 1998 Nov; 61(3):331-3. PubMed ID: 9768568
[TBL] [Abstract][Full Text] [Related]
33. Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal.
Valverde O; Tzavara E; Hanoune J; Roques BP; Maldonado R
Eur J Neurosci; 1996 Dec; 8(12):2671-8. PubMed ID: 8996817
[TBL] [Abstract][Full Text] [Related]
34. Ethanol attenuation of morphine dependence: comparison to dizocilpine.
Shoemaker WJ; Kosten TA; Muly SM
Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370
[TBL] [Abstract][Full Text] [Related]
35. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
36. Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats.
Petrie GN; Wills KL; Piscitelli F; Smoum R; Limebeer CL; Rock EM; Humphrey AE; Sheppard-Perkins M; Lichtman AH; Mechoulam R; Di Marzo V; Parker LA
Psychopharmacology (Berl); 2019 Sep; 236(9):2623-2633. PubMed ID: 30993360
[TBL] [Abstract][Full Text] [Related]
37. Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.
Russell SE; Puttick DJ; Sawyer AM; Potter DN; Mague S; Carlezon WA; Chartoff EH
J Neurosci; 2016 May; 36(21):5748-62. PubMed ID: 27225765
[TBL] [Abstract][Full Text] [Related]
38. Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.
Chartoff EH; Barhight MF; Mague SD; Sawyer AM; Carlezon WA
Psychopharmacology (Berl); 2009 Jun; 204(2):227-39. PubMed ID: 19148621
[TBL] [Abstract][Full Text] [Related]
39. Distinct regulation pattern of Egr-1, BDNF and Arc during morphine-withdrawal conditioned place aversion paradigm: Role of glucocorticoids.
García-Pérez D; Ferenczi S; Kovács KJ; Milanés MV
Behav Brain Res; 2019 Mar; 360():244-254. PubMed ID: 30550948
[TBL] [Abstract][Full Text] [Related]
40. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
